Log In
Print
BCIQ
Print
Print this Print this
 

Xenopax

  Manage Alerts
Collapse Summary General Information
Company Shanghai CP Guojian Pharmaceutical Co. Ltd.
DescriptionImmunosuppressive IgG1 mAb
Molecular Target Interleukin-2 (IL-2) receptor
Mechanism of ActionInterleukin-2 (IL-2) receptor agonist
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentMarketed
Standard IndicationRenal transplant
Indication DetailsPrevent renal transplant rejection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today